Clinical trial
Double Blind Study of Trp01 in Patients With Alzheimer's Disease
NCT00202124 · Queen's University, Other · Completed
Key facts
| NCT number | NCT00202124 |
|---|---|
| Title | Double Blind Study of Trp01 in Patients With Alzheimer's Disease |
| Official title | Double Blind Medium Term Efficacy Study of Trp01 in Patients With Mild to Moderate Alzheimer's Disease |
| Lead sponsor | Queen's University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Tryptophan |
| Enrollment | 12 |
| Start date | Apr 1, 2001 |
| Completion | Mar 1, 2002 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 20, 2005 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: